HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunofluorescence detection of delta opioid receptors (DOR) on human peripheral blood CD4+ T cells and DOR-dependent suppression of HIV-1 expression.

Abstract
The delta opioid receptors (DORs) modulate T cell proliferation, IL-2 production, chemotaxis, and intracellular signaling. Moreover, in DOR-transfected Jurkat cells, delta opioids have been shown to suppress HIV-1 p24 Ag expression. These observations led us to characterize the expression of DORs by human peripheral blood T cells and to determine whether a specific DOR agonist, benzamide,4-([2,5-dimethyl-4-(2-propenyl)-1-piperazinyl](3-methoxyphenyl)methyl]-N,-,(2S[1(S*),2alpha,5beta])-(9Cl) (SNC-80), can suppress p24 Ag expression by HIV-1-infected CD4+ T cells obtained from normal donors. By immunofluorescence flow cytometry, PHA stimulated the expression of DOR from 1.94 +/- 0.70 (mean +/- SEM) to 20.70 +/- 1.88% of the PBMC population by 48 h (p < 0.0001). DOR expression was approximately 40% of both the PHA-stimulated CD4+ and CD8+ T cell subsets, and virtually all DORs were found on these subsets. To determine whether activated DORs suppress HIV-1 expression, PBMC were prestimulated with PHA, and then CD4+ T cells were purified, pretreated with SNC-80, and infected with HIV-1. In a concentration-dependent manner, SNC-80 inhibited production of p24 Ag. SNC-80 10(-10) M maximally suppressed (approximately 50%) both lymphocytotropic (HIV-1 MN) and monocytotropic (SF162) strains; higher concentrations were less effective. Naltrindole, a selective DOR antagonist, abolished the inhibitory effects of SNC-80. Kinetic studies indicated that 24-h pre- or postincubation with SNC-80, relative to infection with HIV-1, eliminated its suppressive effects. Thus, stimulating the DORs expressed by activated CD4+ T cells significantly suppressed the expression of HIV-1. These findings suggest that opioid immunomodulation directed at host T cells may be adjunctive to standard antiviral approaches to HIV-1 infection.
AuthorsB M Sharp, K McAllen, G Gekker, N A Shahabi, P K Peterson
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 167 Issue 2 Pg. 1097-102 (Jul 15 2001) ISSN: 0022-1767 [Print] United States
PMID11441121 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-HIV Agents
  • Immunosuppressive Agents
  • Phytohemagglutinins
  • Receptors, Opioid, delta
Topics
  • Anti-HIV Agents (blood)
  • CD4-Positive T-Lymphocytes (immunology, metabolism, virology)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Cells, Cultured
  • Flow Cytometry
  • Fluorescent Antibody Technique, Direct (methods)
  • HIV-1 (immunology)
  • Humans
  • Immunologic Memory
  • Immunosuppressive Agents (blood)
  • Interphase (immunology)
  • Lymphocyte Activation
  • Male
  • Phytohemagglutinins (pharmacology)
  • Receptors, Opioid, delta (biosynthesis, blood, physiology)
  • Signal Transduction (immunology)
  • Virus Replication (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: